| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/14/2006 | US20060204977 oligonucleotides used for detection and analyzing analytes in solution |
| 09/14/2006 | US20060204974 Screening agents for post-transcriptional control of angiotensin receptors; hypotensive agents |
| 09/14/2006 | US20060204968 Tools for diagnostics, molecular definition and therapy development for chronic inflammatory joint diseases |
| 09/14/2006 | US20060204963 Nucleotide sequences of coryneform bacteria coding for proteins involved in l-serine metabolism and method for producing l-serine |
| 09/14/2006 | US20060204959 Solid support having electrostatic layer and use thereof |
| 09/14/2006 | US20060204958 Methods for diagnosing htlv-i-mediated diseases |
| 09/14/2006 | US20060204954 Compositions and methods for binding agglomeration proteins |
| 09/14/2006 | US20060204584 Materials and methods relating to polyions and substance delivery |
| 09/14/2006 | US20060204566 Novel liposome complexes for increased systemic delivery |
| 09/14/2006 | US20060204523 Flavivirus vaccine delivery system |
| 09/14/2006 | US20060204521 Vector carrying a polynucleotide which encodes a polypeptide having the ability to stimulate an immune response against the polypeptide of Seq ID No:24 |
| 09/14/2006 | US20060204520 Vaccine composition |
| 09/14/2006 | US20060204519 Genetic vaccine for generating immunity to human immunodeficiency virus-1 |
| 09/14/2006 | US20060204516 Compositions and methods for enhancing the immunogenicity of antigens |
| 09/14/2006 | US20060204514 Expression of hydrophobic proteins |
| 09/14/2006 | US20060204510 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 09/14/2006 | US20060204498 Novel antagonists of cxcr3-binding cxc chemokines |
| 09/14/2006 | US20060204492 Compositions and methods for producing enhanced antibodies |
| 09/14/2006 | US20060204489 Protein C derivatives |
| 09/14/2006 | US20060204487 Production of high mannose proteins in plant culture |
| 09/14/2006 | US20060204480 Replication competent virus or its recombinant for use in cancer therapy |
| 09/14/2006 | US20060204479 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 09/14/2006 | US20060204478 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 09/14/2006 | US20060204477 Helper virus-free herpesvirus amplicon particles and uses thereof |
| 09/14/2006 | US20060204475 Melan-a peptide analogue-virus-like-particle conjugates |
| 09/14/2006 | DE10244842B4 Für proteinspaltende Enzyme in Form von spezifischen Proteasen kodierende Nukleinsäuresequenzen, zugehörige Polypeptide und Verwendung von allen For protein-splitting enzymes in the form of specific proteases coding nucleic acid sequences associated polypeptides and use of all |
| 09/14/2006 | DE102005011350A1 CDNA Microarrays mit Zufallsspacern CDNA microarrays with Zufallsspacern |
| 09/14/2006 | CA2603711A1 Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof |
| 09/14/2006 | CA2602084A1 Arabinose- and xylose-fermenting saccharomyces cerevisiae strains |
| 09/14/2006 | CA2601187A1 Novel htmc promoter and vectors for the tumor-selective and high-efficient expression of cancer therapeutic genes |
| 09/14/2006 | CA2601029A1 Photoproteins with enhanced bioluminescence and their use as intracellular calcium indicators |
| 09/14/2006 | CA2600951A1 Growth factor mutants with improved biological activity |
| 09/14/2006 | CA2600749A1 Dimeric or multimeric microproteins |
| 09/14/2006 | CA2599796A1 Near reverse breeding |
| 09/14/2006 | CA2599723A1 Modified transferrin fusion proteins |
| 09/14/2006 | CA2599647A1 Processes using dual specificity oligonucleotide and dual specificity oligonucleotide |
| 09/14/2006 | CA2599577A1 Nucleic acids and proteins and methods for making and using them |
| 09/14/2006 | CA2599405A1 Expression enhancing intron sequences |
| 09/13/2006 | EP1700921A2 Regulation of a human asparagine-hydroxylase |
| 09/13/2006 | EP1700918A2 Activatable recombinant neurotoxins |
| 09/13/2006 | EP1700917A1 Endoglucanase stce and cellulase preparation containing the same |
| 09/13/2006 | EP1700916A1 Novel centromeric protein shugoshin |
| 09/13/2006 | EP1700915A2 Enzymatic DNA molecules |
| 09/13/2006 | EP1700914A1 Development of mammalian genome modification technique using retrotransposon |
| 09/13/2006 | EP1700913A1 Fluorescent proteins |
| 09/13/2006 | EP1700911A1 In vitro method for disassembly/reassembly of papillomavirus virus-like particles (VLPs) |
| 09/13/2006 | EP1700909A2 Transgenic microbial polyhydroxyalkanoate producers |
| 09/13/2006 | EP1700908A2 Transgenic microbial polyhydroxyalkanoate producers |
| 09/13/2006 | EP1700868A2 A method for removing an antibody from blood or plasma |
| 09/13/2006 | EP1700867A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 09/13/2006 | EP1700866A2 Cerebral organic anion transporter and its gene |
| 09/13/2006 | EP1700865A1 Photoproteins with enhanced bioluminescence and their use as intracellular calcium indicators |
| 09/13/2006 | EP1700864A1 Method for the production of S-adenosylmethionine by fermentation |
| 09/13/2006 | EP1700606A1 Therapies for chronic renal failure using one or more integrin antagonists |
| 09/13/2006 | EP1700603A2 Immunostimulatory nucleic acids |
| 09/13/2006 | EP1700524A1 Novel cellulase enzymes and systems for their expression |
| 09/13/2006 | EP1699936A2 Universal amplification of fragmented rna |
| 09/13/2006 | EP1699933A1 Composition for binding a nucleic acid to a solid phase |
| 09/13/2006 | EP1699931A2 Maize metallothionein 2 promoter and methods of use |
| 09/13/2006 | EP1699930A2 Sugar and lipid metabolism regulators in plants vi |
| 09/13/2006 | EP1699929A1 Insect resistant cotton plants and methods of detecting the same |
| 09/13/2006 | EP1699928A2 Stacking crop improvement traits in transgenic plants |
| 09/13/2006 | EP1699927A1 Fatty acid elongase (fae) genes and their utility in increasing erucic acid and other very long-chain fatty acid proportions in seed oil |
| 09/13/2006 | EP1699926A2 Stress tolerant plants and methods thereof |
| 09/13/2006 | EP1699925A1 Il-23 and its receptor; related reagents and methods |
| 09/13/2006 | EP1699924A2 Antisense compounds targeted to connexins and methods of use thereof |
| 09/13/2006 | EP1699923A2 Oligonucleotide and the use thereof for modulating an isoform c beta-1 protein-kinase in the form of a skin depigmentation agent |
| 09/13/2006 | EP1699922A1 COMPOUNDS AND METHODS FOR RNA INTERFERENCE OF THE p65 SUBUNIT OF NF-KAPPA-B |
| 09/13/2006 | EP1699920A2 Novel recombinant proteins with n-terminal free thiol |
| 09/13/2006 | EP1699918A1 High-titer retroviral packaging cells |
| 09/13/2006 | EP1699826A1 Synthetic immunoglobulin domains with binding properties engineered in regions of the molecule different from the complementarity determining regions |
| 09/13/2006 | EP1699825A2 Methods for identifying functional antibodies |
| 09/13/2006 | EP1699824A2 Ztnf 12, a tumor necrosis factor |
| 09/13/2006 | EP1699822A2 Il-7 fusion proteins with antibody portions, their preparation and their use |
| 09/13/2006 | EP1699819A2 Treatment of coronary or peripheral ischemia |
| 09/13/2006 | EP1699817A1 Avidin mutants |
| 09/13/2006 | EP1699816A2 Genes encoding proteins with pesticidal activity |
| 09/13/2006 | EP1699485A2 Anti-hydroxylase antibodies and uses thereof |
| 09/13/2006 | EP1699481A2 Methods and compositions comprising bacteriophage nanoparticles |
| 09/13/2006 | EP1699469A2 Recombinant factor viii having increased specific activity |
| 09/13/2006 | EP1699420A1 Membranes incorporating recognition moieties |
| 09/13/2006 | EP1699413A2 Nucieic acid amplification methods |
| 09/13/2006 | EP1699289A1 Non-human mammal comprising a modified serca2 gene and methods, cells, genes, and vectors thereof |
| 09/13/2006 | EP1649010A4 Novel nucleic acids from sesame plants |
| 09/13/2006 | EP1620555A4 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof |
| 09/13/2006 | EP1552009A4 Method for identifying cellular growth inhibitors |
| 09/13/2006 | EP1543149A4 High resolution analysis of genetic variation within cryptosporidium parvum |
| 09/13/2006 | EP1499887A4 Universal libraries for immunoglobulins |
| 09/13/2006 | EP1499180A4 Cancer models |
| 09/13/2006 | EP1488004B1 Method of concentrating macromolecules or agglomerates of molecules or particles |
| 09/13/2006 | EP1451365A4 Dna amplification and sequencing using dna molecules generated by random fragmentation |
| 09/13/2006 | EP1442135A4 Devices and methods for detecting genetic sequences |
| 09/13/2006 | EP1409723B1 Method of determining dihydropyrimidine dehydrogenase gene expression |
| 09/13/2006 | EP1401962B1 Method for increasing hydrophilicity of fluorescent label compounds |
| 09/13/2006 | EP1389206B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 09/13/2006 | EP1385452B1 Ophthalmic drug delivery device |
| 09/13/2006 | EP1366074B1 Modified granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity |
| 09/13/2006 | EP1364020B1 Position dependent recognition of gnn nucleotide triplets by zinc fingers |
| 09/13/2006 | EP1363944B1 High-affinity antagonists of elr-cxc chemokines |
| 09/13/2006 | EP1360504B1 Method for screening compounds for activity in treating an osteoclast related bone disease |